Deeken Labs Private Limited

Deeken Labs Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24230CH2021PTC043696 Incorporated 01 June 2021 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹2.5 Cr
▲ 142% YoY
Net profit · FY 2024
₹81,796
Net margin 0.3%
EBITDA · FY 2024
₹86,373
EBITDA margin 0.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Deeken Labs Private Limited

Data last updated:

Deeken Labs Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 June 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230CH2021PTC043696. Its GSTIN is 04AAICD5593N1Z4 (Chandigarh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Deepanshu Jain and Jeet Kumar Jain.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Building No. 87 – 88 First Floor Near Gurudwara Raipur Kalan, Chandigarh, India – 160102.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.5 Cr, a growth of 142% compared to the previous year. For the same year it recorded a net profit of ₹81,796 (net margin 0.3%) and EBITDA of ₹86,373 (EBITDA margin 0.3%).

Deeken Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0017423).

Company details

CIN U24230CH2021PTC043696
Registration Number 043696
Incorporation Date 01 June 2021
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-CH-01-0017423

Recognitions & Rankings of Deeken Labs

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-CH-01-0017423

Contact details

Deeken Labs Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Building No. 87 – 88 First Floor Near Gurudwara Raipur Kalan, Chandigarh, India – 160102
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Deeken Labs Private Limited, buy the company report.

Comprehensive company report
Deeken Labs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Deeken Labs is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Deeken Labs Private Limited, buy the company report.

Financials of Deeken Labs Private Limited

FY 2025 filings available

Deeken Labs Private Limited reported revenue of ₹2.5 Cr (up 142% YoY) for FY 2024.

Revenue · FY 2024
₹2.5 Cr ▲ 142%
Net profit · FY 2024
₹81,796 margin 0.3%
EBITDA · FY 2024
₹86,373 margin 0.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 142%
EBITDA CAGR growth
1 year
▲ 120%

Revenue rose 142% in the latest year. EBITDA rose 120% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹86,373
Profit Before Tax
Tax Expense
Net Profit (PAT)₹81,796
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin0.3%
Net Profit Margin0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Deeken Labs Private Limited, buy the company report.

Board of directors of Deeken Labs Private Limited

Deeken Labs has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Deepanshu JainDirector01 Jun 20215 Years 5 MonthsCurrent
Jeet Kumar JainDirector01 Jun 20215 Years 5 MonthsCurrent
Yatin JainDirector01 Jun 20215 Years 5 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Deeken Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Deeken Labs Private Limited has 1 active EPFO establishment as of Apr 05, 2024.

Active EPFO establishments
1

GST

Deeken Labs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
04AAICD5593N1Z4ChandigarhActive22 Oct 2021

To see the full GST registrations and return filing status of Deeken Labs Private Limited, buy the company report.

Recent activity

Deeken Labs Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Deepanshu Jain was appointed as Director on 01 Jun 2021.

AGM
Deeken Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Deeken Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Deepanshu Jain was appointed as Director.
Appointed
Jeet Kumar Jain was appointed as Director.
Appointed
Yatin Jain was appointed as Director.
Incorporation
01 Jun 2021
Deeken Labs Private Limited was registered on 01 Jun 2021 with Roc Chandigarh & aged 5 years 5 months as per MCA records.

Frequently asked questions

Deeken Labs is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 June 2021 (5+ years old) and is registered under CIN U24230CH2021PTC043696.

Deeken Labs has 3 current directors:

The latest financial statements of Deeken Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Deeken Labs is 04AAICD5593N1Z4, registered in Chandigarh.

The CIN (Corporate Identification Number) of Deeken Labs is U24230CH2021PTC043696. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Deeken Labs was incorporated on 01 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chandigarh.

Deepanshu Jain was appointed as Director on 01 Jun 2021. Jeet Kumar Jain was appointed as Director on 01 Jun 2021. Yatin Jain was appointed as Director on 01 Jun 2021.

Yes, Deeken Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0017423).

The registered office of Deeken Labs is at Building No. 87 – 88 First Floor Near Gurudwara Raipur Kalan, Chandigarh, India – 160102.

Deeken Labs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.